Telesis Bio Price on September 11, 2024

TBIODelisted Stock  USD 2.98  0.02  0.67%   
If you're considering investing in Telesis Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Telesis Bio stands at 2.98, as last reported on the 27th of November, with the highest price reaching 3.15 and the lowest price hitting 2.82 during the day. Telesis Bio is out of control given 3 months investment horizon. Telesis Bio owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.1, which indicates the firm had a 0.1% return per unit of risk over the last 3 months. We were able to collect and analyze data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 3.2% are justified by taking the suggested risk. Use Telesis Bio Semi Deviation of 12.47, risk adjusted performance of 0.0594, and Coefficient Of Variation of 1535.52 to evaluate company specific risk that cannot be diversified away.
  
Telesis Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1035

Best PortfolioBest Equity
Good ReturnsTBIO
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 30.89
  actual daily
96
96% of assets are less volatile

Expected Return

 3.2
  actual daily
63
63% of assets have lower returns

Risk-Adjusted Return

 0.1
  actual daily
8
92% of assets perform better
Based on monthly moving average Telesis Bio is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Telesis Bio by adding it to a well-diversified portfolio.

Telesis Bio Valuation on September 11, 2024

It is possible to determine the worth of Telesis Bio on a given historical date. On September 11, 2024 Telesis was worth 1.65 at the beginning of the trading date compared to the closed value of 1.7. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Telesis Bio pink sheet. Still, in general, we apply an absolute valuation method to find Telesis Bio's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Telesis Bio where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Telesis Bio's related companies.
 Open High Low Close Volume
  3.81    3.98    3.78    3.80    59,058  
09/11/2024
  1.65    1.70    1.45    1.70    245,627  
  1.65    2.05    1.63    1.81    476,187  
Backtest Telesis Bio  |  Telesis Bio History  |  Telesis Bio Valuation   PreviousNext  
Open Value
1.65
1.7
Closing Value
94.32
Upside

Telesis Bio Trading Date Momentum on September 11, 2024

On September 12 2024 Telesis Bio was traded for  1.81  at the closing time. The top price for the day was 2.05  and the lowest listed price was  1.63 . The trading volume for the day was 476.2 K. The trading history from September 12, 2024 was a factor to the next trading day price boost. The trading price change against the next closing price was 6.47% . The trading price change against the current closing price is 75.88% .

Telesis Bio Fundamentals Correlations and Trends

By evaluating Telesis Bio's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Telesis Bio's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Telesis financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Telesis Bio Pink Sheet history

Telesis Bio investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Telesis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Telesis Bio will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Telesis Bio stock prices may prove useful in developing a viable investing in Telesis Bio
Translate Bio, Inc., a clinical-stage messenger RNA therapeutics company, develops medicines to treat diseases caused by protein or gene dysfunction. The company was founded in 2011 and is headquartered in Lexington, Massachusetts. Translate Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 122 people.

Telesis Bio Pink Sheet Technical Analysis

Telesis Bio technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Telesis Bio technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Telesis Bio trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Telesis Bio Period Price Range

Low
November 27, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Telesis Bio cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Telesis Bio November 27, 2024 Market Strength

Market strength indicators help investors to evaluate how Telesis Bio pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Telesis Bio shares will generate the highest return on investment. By undertsting and applying Telesis Bio pink sheet market strength indicators, traders can identify Telesis Bio entry and exit signals to maximize returns

Telesis Bio Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Telesis Bio's price direction in advance. Along with the technical and fundamental analysis of Telesis Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Telesis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Consideration for investing in Telesis Pink Sheet

If you are still planning to invest in Telesis Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Telesis Bio's history and understand the potential risks before investing.
CEOs Directory
Screen CEOs from public companies around the world
FinTech Suite
Use AI to screen and filter profitable investment opportunities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Share Portfolio
Track or share privately all of your investments from the convenience of any device